The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
Benchmark:
NIFTY PHARMA
Fund Manager:
Shibani Sircar Kurian, Dhananjay Tikariha, Abhishek Bisen, Arjun Khanna
Mirae Asset Healthcare Fund | 27.65(6M) | 24.31(1Y) |
Nippon India Pharma Fund | 29.59(6M) | 29.68(1Y) |
A fund with pharma and medical services as the investment universe.
Fund House AAUM:
Rs. 33632410.49 Lakhs (as on 30th September 2023)
Fund Manager:
Combined experience of above 20 years
Nil. Period. What oomph??